Announcements Trials
Browse Landscape

Status

Completed 17Active not recruiting 10Terminated 7Withdrawn 4Recruiting 4Suspended 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 65INDUSTRY 17OTHER_GOV 3NIH 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 4Carcinoma, Non-Small-Cell Lung 3Prostatic Neoplasms 2Neoplasms 2Multiple Myeloma 2Lung Neoplasms 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Recurrence 1Pulmonary Blastoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Pancreatic Neoplasms 1Pain, Intractable 1Neuroblastoma 1Neoplasms, Glandular and Epithelial 1Neoplasms by Histologic Type 1Myelodysplastic Syndromes 1Melanoma, Cutaneous Malignant 1Melanoma 1Lymphoma 1Li-Fraumeni Syndrome 1Leukemia, Plasma Cell 1Leukemia 1Legius syndrome 1Hematologic Neoplasms 1Gliosarcoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × NIH × Triple Negative Breast Neoplasms × Clear all
NCT07619534 2026-06-04

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

National Institutes of Health Clinical Center (CC)

Not yet recruiting
139 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡